Skip to main content

IDEX Value Stock - Dividend - Research Selection

Idex

ISIN: US45167R1041 , WKN: 877444

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

IDEX Corporation, together with its subsidiaries, operates as an applied solutions company worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as offers flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries. The HST segment provides precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction, and drying systems for use in beverage, food processing, pharmaceutical, and cosmetics; pneumatic components and sealing solutions, such as pumping solutions for analytical instrumentation, clinical diagnostics, and drug discovery; molded and extruded sealing components; custom mechanical and shaft seals; engineered hygienic mixers and valves; biocompatible medical devices and implantables; and air compressors. This segment also offers optical components and coatings for applications in the scientific research, defense, biotechnology, aerospace, telecommunications, and electronics manufacturing applications; laboratory and commercial equipment to produce micro and nano scale materials; precision photonic solutions; and precision gear and peristaltic pump technologies. The FSDP segment produces and distributes firefighting pumps, valves and controls, rescue tools, lifting bags, and other components and systems for the fire and rescue industry; engineered stainless steel banding and clamping devices for various industrial and commercial applications; and precision equipment for dispensing, metering, and mixing colorants and paints used in retail and commercial businesses. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


IDEX First Quarter 2025 Earnings: In Line With Expectations

2025-05-03
IDEX ( NYSE:IEX ) First Quarter 2025 Results Key Financial Results Revenue: US$814.3m (up 1.7% from 1Q 2024). Net...

IDEX Corp (IEX) Q1 2025 Earnings Call Highlights: Record Orders and Strategic Growth Amidst ...

2025-05-02
IDEX Corp (IEX) surpasses expectations with record-level orders and strategic acquisitions, despite facing organic sales declines and margin pressures.

Q1 2025 IDEX Corp Earnings Call

2025-05-02
Q1 2025 IDEX Corp Earnings Call

IDEX Corporation 2025 Q1 - Results - Earnings Call Presentation

2025-05-02
The following slide deck was published by IDEX Corporation in conjunction with their 2025 Q1 earnings call.

IDEX Corporation (IEX) Q1 2025 Earnings Call Transcript

2025-05-02
IDEX Corporation (NYSE:IEX) Q1 2025 Earnings Call May 1, 2025 9:00 AM ETCompany ParticipantsJim Giannakouros - Investor RelationsEric Ashleman - President...

IDEX Q1 Earnings Surpass Estimates, Sales Increase Year Over Year

2025-05-01
Strength in the Health & Science Technologies segment aids IEX's first-quarter results.

IDEX Corporation: There Is Upside Potential

2025-05-01
IDEX Corporation achieves growth through strategic acquisitions, consistent dividend increases, and strong earnings performance. Learn more on IEX stock here.

IDEX (NYSE:IEX) Surprises With Q1 Sales

2025-05-01
Manufacturing company IDEX (NYSE:IEX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.7% year on year to $814.3 million. Its non-GAAP profit of $1.75 per share was 6.7% above analysts’ consensus estimates.

IDEX tops quarterly estimates on demand for health and science products

2025-05-01
Industrial equipment maker IDEX Corp on Thursday beat Wall Street estimates for first-quarter profit and revenue, driven by a sustained recovery in the demand for its health and science-related products. Demand for such products has been rising as sellers continue to restock their inventory after a prolonged period of drawdowns caused by large stockpiles accumulated during the COVID-19 pandemic. Sales at IDEX's health and sciences technology segment, which makes components used in clinical diagnostics, drug discovery, food-processing industry, among others, rose 10% from a year ago.

Idex: Q1 Earnings Snapshot

2025-05-01
The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.64 per share. The maker of the Jaws of Life device and other engineered products posted revenue of $814.3 million in the period, which also beat Street forecasts.